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Background
In 2011, Royston et al. described technical details of a
two-arm, multi-stage (TAMS) design. The design
enables a trial to be stopped part-way through recruit-
ment if the accumulating data suggests a lack of benefit
of the experimental arm. Such interim decisions can be
made using data on an available `intermediate’ outcome.
At the conclusion of the trial, the definitive outcome is
analysed. Typical intermediate and definitive outcomes
in cancer might be progression-free and overall survival,
respectively. In TAMS designs, the stopping rule applied
at the interim stage(s) affects the sampling distribution
of the treatment effect estimator, potentially inducing
bias that needs addressing.
Methods
Using simulations, we quantified the bias in the treat-
ment effect estimator in TAMS trials for different
designs. We also retrospectively `re-designed’ completed
cancer trials as TAMS trials and used the bootstrap to
quantify bias.
Results
In trials in which the experimental treatment is better
than the control and which continue to their planned
end, the bias in the estimate of treatment effect is small
and of no practical importance. In trials stopped for lack
of benefit at an interim stage, the treatment effect esti-
mate is biased at the time of interim assessment. This
bias is markedly reduced by further patient follow-up and
reanalysis at the planned `end’ of the trial.
Conclusions
Provided that all patients in a TAMS trial are followed
up to the planned end of the trial, the bias in the esti-
mated treatment effect is of no practical importance.
Bias correction is then unnecessary.
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